Who has invested in XinThera?

Foresite Capital, TTM Capital, Orbimed Advisors are named among the investors backing XinThera.

XinThera Funding: $80M Raised, Series B (2021)

XinThera funding overview

XinThera is based in San Diego, California. XinThera has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for XinThera runs through 2021; nothing later has been disclosed. Investors on record include Foresite Capital, TTM Capital, Orbimed Advisors. 3 distinct backers are named across the disclosed rounds.

XinThera at a glance

Total raised: $80M
Latest round: Series B
Latest round date: August 2021
Headquarters: San Diego, California
Notable investors: Foresite Capital, TTM Capital, Orbimed Advisors

Frequently asked about XinThera funding

How much has XinThera raised?: XinThera has raised $80M in total disclosed funding across the rounds on record.
Who has invested in XinThera?: Foresite Capital, TTM Capital, Orbimed Advisors are named among the investors backing XinThera.
What was the latest XinThera funding round?: The most recent disclosed round is a Series B, announced in August 2021.
Where is XinThera based?: XinThera is based in San Diego, California.
When did XinThera last raise?: The last disclosed XinThera round closed in August 2021 at Series B.

XinThera totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

XinThera Funding: $80M Raised, Series B (2021)

XinThera funding overview

XinThera at a glance

Frequently asked about XinThera funding

Companies related to XinThera (34)

Browse related funding lists (7)